Cargando…
Clinical and Public Health Considerations for HPV Vaccination in Midadulthood: A Narrative Review
Human papillomavirus (HPV) is an important cause of anogenital and oropharyngeal cancers, anogenital warts, and recurrent respiratory papillomatosis. Beginning in 2019, US guidelines recommended shared clinical decision-making (SCDM) for HPV vaccination among midadults (27–45 years). We conducted a...
Autores principales: | King, Laura M, Lewnard, Joseph A, Niccolai, Linda M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887268/ https://www.ncbi.nlm.nih.gov/pubmed/36726535 http://dx.doi.org/10.1093/ofid/ofad004 |
Ejemplares similares
-
Impact of Ideal Cardiovascular Health in Childhood on the Retinal Microvasculature in Midadulthood: Cardiovascular Risk in Young Finns Study
por: Campbell, Matthew D., et al.
Publicado: (2018) -
Associations of Cannabis Use across Adolescence and Early Adulthood
With Health and Psychosocial Adjustment in Early Adulthood and Midadulthood in
Men
por: Capaldi, Deborah M, et al.
Publicado: (2022) -
Effectiveness of HPV vaccine by age at vaccination and number of doses: protocol for a population-based matched case–control study
por: Oliveira, Carlos R, et al.
Publicado: (2021) -
Monitoring the impact of HPV vaccine in males—Considerations and challenges
por: Brotherton, Julia M.L., et al.
Publicado: (2016) -
Public health considerations regarding golf during the COVID-19 pandemic: a narrative review
por: Robinson, Patrick Gordon, et al.
Publicado: (2021)